LeMaitre Vascular
LMAT
166 hedge funds and large institutions have $486M invested in LeMaitre Vascular in 2018 Q2 according to their latest regulatory filings, with 27 funds opening new positions, 74 increasing their positions, 40 reducing their positions, and 14 closing their positions.
93% more first-time investments, than exits
New positions opened: 27 | Existing positions closed: 14
85% more repeat investments, than reductions
Existing positions increased: 74 | Existing positions reduced: 40
8% more funds holding
Funds holding: 154 → 166 (+12)
6.73% more ownership
Funds ownership: 73.19% → 79.92% (+6.7%)
5% less capital invested
Capital invested by funds: $511M → $486M (-$25.8M)
67% less funds holding in top 10
Funds holding in top 10: 3 → 1 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RIM
Ranger Investment Management
Dallas,
Texas
|
+$11M |
| 2 |
EIP
Epoch Investment Partners
New York
|
+$5.72M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$5.62M |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$5.45M |
| 5 |
Millennium Management
New York
|
+$4.17M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Ameriprise
Minneapolis,
Minnesota
|
-$3.23M |
| 2 |
SI
Sensato Investors
San Francisco,
California
|
-$2.63M |
| 3 |
Allianz Asset Management
Munich,
Germany
|
-$2.2M |
| 4 |
GPGA
Grandeur Peak Global Advisors
Salt Lake City,
Utah
|
-$2.2M |
| 5 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
-$2.08M |
LMAT Hedge Fund Activity: Q2 2018 in Review
166 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in LeMaitre Vascular (LMAT) for Q2 2018, worth a combined $486M — down 5% from $511M a quarter earlier.
Buyers outnumbered sellers: 27 funds opened new LMAT positions and 14 closed out — a net gain of 13 holders — while 74 added to existing stakes and 40 trimmed.
The largest buyer was Ranger Investment Management, adding an estimated $11M. The largest seller was Ameriprise, cutting an estimated $3.23M.
- 166 institutional investors held LeMaitre Vascular (LMAT) as of Q2 2018, up from 154 in Q1 2018.
- Funds reported $486M of LeMaitre Vascular stock for Q2 2018, down 5% quarter-over-quarter.
- 27 funds opened new LeMaitre Vascular positions in Q2 2018 and 14 closed out, a net change of +13 holders.
- The largest LeMaitre Vascular buyer in Q2 2018 was Ranger Investment Management, an estimated $11M added.
- The largest LeMaitre Vascular seller in Q2 2018 was Ameriprise, an estimated $3.23M sold.
Based on aggregated 13F filings for Q2 2018.